| # | Ticker | Company | Price | Chg % | Mkt Cap | P/E | EPS Growth TTM | Div Yield | Sector | Return 1Y | Revenue Growth… | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Alnylam Pharmaceuticals, Inc. | $321.59 | 2.7% | $42.91B | 138.0 | 301.4% | — | Healthcare | -0.8% | 82.6% | ||
| 2 | Ionis Pharmaceuticals, Inc. | $86.33 | 3.8% | $14.27B | -36.3 | 30.1% | — | Healthcare | 106.6% | 47.5% | ||
| 3 | Arrowhead Pharmaceuticals, Inc. | $86.97 | 0.5% | $12.25B | -7128.7 | -50.7% | — | Healthcare | 416.4% | 14.1% | ||
| 4 | CRISPR Therapeutics AG | $60.77 | -1.8% | $5.86B | -9.4 | -37.6% | — | Healthcare | 18.7% | -88.9% | ||
| 5 | Beam Therapeutics Inc. | $37.92 | 7.4% | $3.9B | -46.8 | 85.2% | — | Healthcare | 97.7% | 108% | ||
| 6 | Stoke Therapeutics, Inc. | $32.71 | -0% | $2.04B | -272.6 | -458.2% | — | Healthcare | 179.8% | -83.2% | ||
| 7 | Intellia Therapeutics, Inc. | $17.43 | -2.3% | $1.96B | -4.6 | 32.3% | — | Healthcare | 70% | 45% | ||
| 8 | Wave Life Sciences Ltd. | $6.38 | 0.9% | $1.23B | -5.3 | -26.2% | — | Healthcare | -9.6% | -31.6% | ||
| 9 | Arbutus Biopharma Corporation | $5.18 | 4.2% | $1.02B | -30.5 | 302.1% | — | Healthcare | 65% | 2889.9% | ||
| 10 | Design Therapeutics, Inc. | $14.71 | -0.9% | $919M | -12.1 | -21.2% | — | Healthcare | 315.5% | — | ||
| 11 | Prime Medicine, Inc. | $3.99 | 0% | $721M | -3.0 | 23.5% | — | Healthcare | 5% | 4.9% | ||
| 12 | Silence Therapeutics plc | $10.15 | -4.1% | $479M | -5.4 | -1.7% | — | Healthcare | 77.1% | -96.8% | ||
| 13 | Editas Medicine, Inc. | $3.75 | 2.7% | $367M | -2.1 | 59.6% | — | Healthcare | 47.6% | 8% | ||
| 14 | Atrium Therapeutics, Inc. | $13.24 | 1.8% | $226M | -3.0 | -71.1% | — | Healthcare | -54% | 312.4% | ||
| 15 | Arcturus Therapeutics Holdings Inc. | $7.60 | 3.4% | $216M | -3.2 | -11.9% | — | Healthcare | -43.1% | -66.4% | ||
| 16 | ProQR Therapeutics N.V. | $1.66 | -3.5% | $175M | -3.8 | -27.1% | — | Healthcare | -22.4% | -29.2% | ||
| 17 | Korro Bio, Inc. | $14.49 | 3.1% | $144M | -1.2 | -23.7% | — | Healthcare | 15.2% | -20.3% | ||
| 18 | PepGen Inc. | $2.05 | 8.5% | $142M | -1.0 | 32.9% | — | Healthcare | 84.7% | — | ||
| 19 | Precision BioSciences, Inc. | $9.25 | 12.3% | $119M | -2.5 | -57% | — | Healthcare | 114.6% | -11.9% | ||
| 20 | CAMP4 Therapeutics Corporation | $4.40 | 2.8% | $93M | -1.7 | 19.2% | — | Healthcare | 212.1% | 160.5% | ||
| 21 | Metagenomi, Inc. Common Stock | $1.32 | 5.6% | $50M | -0.6 | -9% | — | Healthcare | -21.9% | -50.7% | ||
| 22 | Aligos Therapeutics, Inc. | $6.09 | 4.1% | $38M | -2.5 | 50.2% | — | Healthcare | -18.8% | 43.9% | ||
| 23 | Sangamo Therapeutics, Inc. | $0.07 | 0% | $31M | -0.2 | 2.2% | — | Healthcare | -85.5% | -45.8% | ||
| 24 | Exicure, Inc. | $1.90 | -4.5% | $12M | -2.4 | -67.5% | — | Healthcare | -70.6% | — | ||
| 25 | Phio Pharmaceuticals Corp. | $1.01 | 2% | $12M | -0.7 | 100% | — | Healthcare | -60.4% | — | ||
| 26 | TransCode Therapeutics, Inc. | $8.44 | 12.1% | $8M | -0.2 | 49.3% | — | Healthcare | 4.8% | — | ||
| 27 | Silexion Therapeutics Ltd. | $2.70 | -5.3% | $872200 | -0.0 | 403.1% | — | Healthcare | -97.8% | — | ||
| 28 | Silexion Therapeutics Ltd. | $0.03 | -17.4% | $8108 | -0.0 | 403.1% | — | Healthcare | -35% | — |